Free Trial
NASDAQ:NTRB

Nutriband (NTRB) Stock Price, News & Analysis

Nutriband logo
$7.13 +0.18 (+2.59%)
Closing price 08/7/2025 04:00 PM Eastern
Extended Trading
$6.92 -0.21 (-2.99%)
As of 08:38 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Nutriband Stock (NASDAQ:NTRB)

Key Stats

Today's Range
$6.83
$7.15
50-Day Range
$6.22
$10.72
52-Week Range
$3.72
$11.78
Volume
22,030 shs
Average Volume
34,632 shs
Market Capitalization
$79.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00
Consensus Rating
Buy

Company Overview

Nutriband Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
55th Percentile Overall Score

NTRB MarketRank™: 

Nutriband scored higher than 55% of companies evaluated by MarketBeat, and ranked 471st out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nutriband has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Nutriband has received no research coverage in the past 90 days.

  • Read more about Nutriband's stock forecast and price target.
  • Earnings Growth

    Earnings for Nutriband are expected to grow in the coming year, from ($0.60) to ($0.56) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nutriband is -7.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nutriband is -7.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Nutriband has a P/B Ratio of 12.29. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Nutriband's valuation and earnings.
  • Percentage of Shares Shorted

    2.10% of the float of Nutriband has been sold short.
  • Short Interest Ratio / Days to Cover

    Nutriband has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nutriband has recently decreased by 12.91%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Nutriband does not currently pay a dividend.

  • Dividend Growth

    Nutriband does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.10% of the float of Nutriband has been sold short.
  • Short Interest Ratio / Days to Cover

    Nutriband has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nutriband has recently decreased by 12.91%, indicating that investor sentiment is improving significantly.
  • MarketBeat Follows

    2 people have added Nutriband to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nutriband insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    54.09% of the stock of Nutriband is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 19.70% of the stock of Nutriband is held by institutions.

  • Read more about Nutriband's insider trading history.
Receive NTRB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutriband and its competitors with MarketBeat's FREE daily newsletter.

NTRB Stock News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
See More Headlines

NTRB Stock Analysis - Frequently Asked Questions

Nutriband's stock was trading at $4.71 on January 1st, 2025. Since then, NTRB shares have increased by 51.4% and is now trading at $7.13.

Nutriband Inc. (NASDAQ:NTRB) released its quarterly earnings data on Friday, May, 30th. The company reported ($0.12) EPS for the quarter, beating analysts' consensus estimates of ($0.13) by $0.01. The company had revenue of $0.67 million for the quarter, compared to analyst estimates of $0.71 million. Nutriband had a negative trailing twelve-month return on equity of 68.25% and a negative net margin of 415.93%.

Nutriband shares split on Monday, August 15th 2022.The 13-6 split was announced on Monday, August 15th 2022. The newly created shares were payable to shareholders after the closing bell on Monday, August 15th 2022. An investor that had 100 shares of stock prior to the split would have 217 shares after the split.

Top institutional shareholders of Nutriband include Consolidated Portfolio Review Corp (0.09%).

Shares of NTRB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nutriband investors own include Jiuzi (JZXN), AMC Entertainment (AMC), Aridis Pharmaceuticals (ARDS), Avenue Therapeutics (ATXI), Esports Entertainment Group (GMBL), Moleculin Biotech (MBRX) and ARMOUR Residential REIT (ARR).

Company Calendar

Last Earnings
5/30/2025
Today
8/08/2025
Next Earnings (Estimated)
9/02/2025
Fiscal Year End
1/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NTRB
CIK
1676047
Fax
N/A
Employees
10
Year Founded
N/A

Price Target and Rating

High Price Target
$13.00
Low Price Target
$13.00
Potential Upside/Downside
+82.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.90)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.48 million
Net Margins
-415.93%
Pretax Margin
-415.93%
Return on Equity
-68.25%
Return on Assets
-60.40%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
3.71
Quick Ratio
3.48

Sales & Book Value

Annual Sales
$2.14 million
Price / Sales
37.15
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.58 per share
Price / Book
12.29

Miscellaneous

Outstanding Shares
11,150,000
Free Float
5,121,000
Market Cap
$79.50 million
Optionable
Not Optionable
Beta
1.13

Social Links

10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:NTRB) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners